Indianapolis, INNCT06293365Now EnrollingIRB Ready

Autoimmune Disease Clinical Trial in Indianapolis, IN

Access cutting-edge autoimmune disease treatment through this clinical trial at a research site in Indianapolis. Study-provided care at no cost to qualified participants.

Sponsored by Novartis Pharmaceuticals

Quick Self-Assessment

See if you qualify for this Indianapolis location

Preparing your pre-screening questions...

Expert Care in Indianapolis

Access autoimmune disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related autoimmune disease treatment provided free

Apply for This Indianapolis Location

Check if you qualify for this autoimmune disease clinical trial in Indianapolis, IN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Indianapolis

    Convenient for IN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Indianapolis site if eligible
  4. 4Begin participation

About This Autoimmune Disease Study in Indianapolis

The purpose of this study is to demonstrate the comparability of ianalumab exposure following the sub-cutaneous (s.c.) administration of one injection of 300 mg/2 mL auto-injector (AI) versus two injections of 150 mg/1 mL pre-filled syringe (PFS), and to evaluate the safety and tolerability of ianalumab following the s.c. administration of both devices in participants with rheumatoid arthritis (RA), Sjögren's disease (SjD), or systemic lupus erythematosus (SLE). A second cohort will be included

Sponsor: Novartis Pharmaceuticals

Who Can Participate

Inclusion Criteria

Signed informed consent must be obtained before any assessment is performed.
Male and female patients aged 18 years to 70 years (inclusive).
Body weight at least 35 kg and not more than 150 kg and must have a body mass index (BMI) within the range of 18 - 35 kg/m2. BMI = Body weight (kg) / \[Height (m)\]2 at screening.
Diagnosed with RA, SjD and/or SLE as determined by the investigator.
Have active disease (RA, SjD or SLE) that may benefit from B-cell depletion therapy, as determined by the investigator.
Participants currently receiving protocol-allowed SoC should be on stable doses of SoC medications for 4 weeks prior to first dosing of study treatment.
Ability to communicate well with the investigator, understand and agree to comply with the requirements of the study. Key

Exclusion Criteria

Use of prohibited therapies.
Active viral, bacterial or other infections requiring systemic treatment at the time of screening or baseline or history

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Indianapolis?

Yes, this clinical trial (NCT06293365) has an active research site in Indianapolis, IN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Autoimmune Disease Treatment Options in Indianapolis, IN

If you're searching for autoimmune disease treatment options in Indianapolis, IN, this clinical trial (NCT06293365) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Indianapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced autoimmune disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all autoimmune disease clinical trials near you to find additional studies recruiting in your area.

More Multiple Myeloma Trials in Indianapolis, IN

See all multiple myeloma clinical trials recruiting in Indianapolis — not just this study.

Browse Multiple Myeloma Trials in Indianapolis →

Browse More Trials by Condition

Multiple Myeloma TrialsAnkylosing Spondylitis TrialsOsteogenesis Imperfecta TrialsAll Conditions →

Ready to Join in Indianapolis?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Indianapolis, IN